E Therapeutics (ETX)

 

ETX Share PerformanceMore

52 week high13.90 29/07/16
52 week low6.00 01/06/17
52 week change -0.25 (-2.08%)
4 week volume17,327,131 28/06/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

e-Therapeutics completes 'root and branch' review

e-Therapeutics has completed a 'root and branch' strategic review which, it said, had confirmed the novelty, utility and pro...

Outcome of Strategic Review and Future Plans

RNS Number: 8126L e-Therapeutics plc 24 July 2017 E-THERAPEUTICS PLC ("e-Therapeutics" or the "Company") E-Therapeutics announces outcome of Strategic Review AND FUTURE PLANS Oxford, UK, 24 July 2017 , e-Therapeutics plc (AIM: ETX): Upon the completion of Ray Barlow's first three months as CEO of e-Therapeutics, the Company outlines below...

Director Deals - e-Therapeutics PLC (ETX)

Prof Trevor Jones, Non Executive Director, bought 45,364 shares in the company on the 3rd July 2017 at a price of 12.13p. T...

Director/PDMR Shareholding

RNS Number: 9843J e-Therapeutics plc 03 July 2017 E-THERAPEUTICS PLC ("e-Therapeutics" or the "Company") NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND ISSUE OF EQUITY Oxford, UK, 3 July 2017 - e-Therapeutics plc (AIM: ETX), the drug discovery compa...

TR-1: Notification of Major Interest in Shares

RNS Number: 4582I e-Therapeutics plc 19 June 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii E Therapeutics Plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights X An acquisition ...

TR-1: Notification of Major Interest in Shares

RNS Number: 1755H e-Therapeutics plc 05 June 2017 For filings with the FCA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii e-Therapeutics plc 2 Reason for the notification (please tick the a...

TR-1: Notification of Major Interest in Shares

RNS Number: 0578H e-Therapeutics plc 02 June 2017 For filings with the FCA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii e-Therapeutics plc 2 Reason for the notification (please tick the a...

TR-1: Notification of Major Interest in Shares

RNS Number: 0526H e-Therapeutics plc 02 June 2017 For filings with the FSA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii E Therapeutics Plc 2 Reason for the notification (please tick the ...

Fundamental DataMore

EPS-4.91
Dividend yield0 %

Equity Research (ETX)

edison investment research
e-Therapeutics plc
05/05/2017
e-Therapeutics offers public market investors a unique opportunity to gain exposure to a proprietary, cutting-edge in silico drug discovery platform that has already attracted significant investment...
edison investment research
e-Therapeutics plc
16/01/2017
e-Therapeutics (ETX) has appointed a new CEO, Dr Raymond Barlow, who will join the company by 1 May 2017. He brings significant R&D and business development experience, which will be invaluable...
edison investment research
e-Therapeutics plc.
20/09/2016
e-Therapeutics (ETX) is focused on driving value in its discovery platform. Costs will be reduced as the 17 product candidates in discovery as of July 2016 have been cut to a core five. Cash of £19....

Latest discussion posts More

  • Q1 2017 blog update - ETX

    Q1 2017 blog weekly ETX chart update - notes under each chart: http://bonker99.com/Blogs
    10-Feb-2017
    Bonker
  • ETX chart

    http://bonker99.com/charts
    6-Feb-2017
    Bonker
  • Results

    RNS available at company's website. although seems to be missing in III ...
    22-Mar-2016
    nk1999

Users' HoldingsMore

Users who hold E Therapeutics also hold..
LLOYDS GRP.28%
ROCKHOPPER28%
RANGE RES.24%
RENEURON24%
VODAFONE GRP.20%

Codes & Symbols

ISINGB00B2823H99
SymbolsETX, LSE:ETX, ETX.L, ETX:LN, LON:ETX, XLON:ETX